Tag: spine biologics market drivers

Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

What is the Expected Growth Rate of the Spine Biologics Market from 2024 to 2033?
The spine biologics market has seen strong growth, projected to rise from $2.24 billion in 2023 to $2.36 billion in 2024, with a CAGR of 5.3%. This growth can be attributed to biotechnology advancements, an aging population, high spinal disorder rates, and a preference for minimally invasive procedures.

The spine biologics market is expected to grow to $2.91 billion by 2028 at a CAGR of 5.4%. Growth is linked to technological innovations, the adoption of regenerative medicine, and favorable regulatory approvals. Trends include the emergence of novel therapies, AI integration in treatment planning, and development of bioengineered scaffolds for enhanced tissue regeneration.

Claim Your Free Sample of the Global Spine Biologics Market Report Today!
https://www.thebusinessresearchcompany.com/sample.aspx?id=15928&type=smp

What Key Factors Are Fueling the Growth of the Spine Biologics Market?
The spinal biologics market is expected to grow as road accidents increase. These incidents often result in severe spinal injuries requiring advanced medical treatment. Factors contributing to the rise in road accidents include distracted driving, higher traffic volumes, poor road conditions, and substance impairment. Spinal biologics are crucial in improving patient outcomes by facilitating spinal fusion, accelerating healing, lowering surgical risks, enhancing pain management, and reducing the need for revision surgeries. The National Highway Traffic Safety Administration reported in May 2022 that around 42,915 people died in U.S. traffic crashes in 2021, marking a 10.5% increase from 2020. Thus, the increase in road accidents is propelling the spinal biologics market.

What Are the Major Segments of the Spine Biologics Market?
1) By Product: Bone Allografts, Bone Graft Substitute, Platelet Rich Plasma, Bone Marrow Aspirate Therapy
2) By Surgery Type: Anterior Cervical Discectomy And Fusion (ACDF), ??Posterior Lumbar Interbody Fusion (PLIF), Transforaminal Lumbar Interbody Fusion (TLIF), ??Anterior Lumbar Interbody Fusion (ALIF), ??Lateral Lumbar Interbody Fusion (LLIF), Other Surgery Types
3) By Application: Spinal Fusion, Spinal Non-Union And Fracture Repair, Degenerative Disc Disease Treatment, Other Applications
4) By End User: Hospitals, Spinal Surgery Centers, Orthopedic Clinics, Other End Users

What New Trends Are Transforming the Spine Biologics Market?
In the spinal biologics market, companies are creating synthetic bioactive bone grafts to enhance patient care. For example, in February 2022, Orthofix Medical Inc. launched Opus BA, a synthetic bone graft designed for cervical and lumbar spine fusion, promoting bone growth and healing.

Order Now for Fast Delivery of Your Spine Biologics Market Report!
https://www.thebusinessresearchcompany.com/report/spine-biologics-global-market-report

Which Regions Are Driving Growth in the Spine Biologics Market?
North America was the largest region in the spine biologics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the spine biologics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The Spine Biologics Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the spine biologics market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Spine Biologics Market Include

1. Spine Biologics Market Executive Summary
2. Spine Biologics Market Segments
3. Spine Biologics Market Size And Template Market Growth Rate
4.  Key Spine Biologics Market Trends
5. Major Spine Biologics Market Drivers
……
25. Key Mergers And Acquisitions In The Spine Biologics Market
26. Top Spine Biologics Companies
27. Spine Biologics Market Opportunities And Strategies
28. Spine Biologics Market, Conclusions And Recommendations
29. Appendix

Discover Related Reports by The Business Research Company:
Acute Spinal Cord Injury Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/acute-spinal-cord-injury-global-market-report

Spinal Cord Stimulation Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/spinal-cord-stimulation-global-market-report

Spinal Surgery Devices And Equipment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/spinal-surgery-devices-and-equipment-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

According to The Business Research Company’s Spine Biologics Global Market Report 2024, the spine biologics market is expected to show promising growth in the forecast period.

Robust Market Growth in Recent Years

• Market Size in 2023: The spine biologics market has seen significant growth, reaching $2.24 billion in 2023.
• Growth Rate: It is projected to grow to $2.36 billion in 2024 at a CAGR of 5.3%.
• Historic Growth Drivers: Key factors include advancements in biotechnology, an aging population, a high incidence of spinal disorders, increased preference for minimally invasive procedures, high awareness about spine health, improvements in diagnostic techniques, and enhanced healthcare infrastructure.

Strong Growth Expected in Coming Years

• Future Market Size: The market is expected to grow to $2.91 billion by 2028, with a CAGR of 5.4%.
• Forecast Growth Drivers: Anticipated growth factors include technological innovations, increasing adoption of regenerative medicine, rising investment in R&D, growing prevalence of obesity and sedentary lifestyles, expanding healthcare access in emerging markets, favorable regulatory approvals, and increasing industry collaborations and partnerships.
• Trends to Watch: Key trends include the emergence of novel regenerative therapies, integration of artificial intelligence in treatment planning, expansion of personalized medicine approaches, adoption of 3D printing for customized implants, and development of bioengineered scaffolds for enhanced tissue regeneration.

View More On The Spine Biologics Market Report 2024 – https://www.thebusinessresearchcompany.com/report/spine-biologics-global-market-report

Rising Number of Road Accidents Drives Market Growth

• Impact of Road Accidents: The rising number of road accidents globally is expected to propel the growth of the spine biologics market due to the need for advanced medical interventions for spinal injuries.
• Statistics: According to the National Highway Traffic Safety Administration, an estimated 42,915 people died in motor vehicle traffic crashes in 2021 in the US, marking a 10.5% rise from the 38,824 fatalities in 2020.
• Role of Spine Biologics: Spine biologics play a crucial role in improving patient outcomes by enhancing spinal fusion, speeding up healing, lowering surgical risks, improving pain management, and reducing the need for revision operations.

Major Players in the Spine Biologics Market

• Key Companies: Notable players include Johnson & Johnson Services Inc., Medtronic PLC, Stryker Corporation, Baxter International Inc., B. Braun Melsungen AG, Zimmer Biomet Holdings Inc., Arthrex Inc., Integra LifeSciences Corporation, Bone Biologics Corp., InVivo Therapeutics Corp., RTI Surgical Inc., Paragon 28 Inc., LifeNet Health Inc., Xtant Medical Holdings Inc., Kuros Biosciences A.G., CoreLink LLC, Spinal Elements Inc., Life Spine Inc., Innovasis Inc., Camber Spine Technologies LLC, SurGenTec LLC, ChoiceSpine LLC, Cerapedics Inc., Aziyo Biologics, Amedica Corporation.

Innovative Synthetic Bioactive Bone Grafts for Spinal Fusion Procedures

• Advanced Products: Companies are developing synthetic bioactive bone grafts to better serve patients and gain a competitive edge in the market.
• Example: In February 2022, Orthofix Medical Inc. launched Opus BA, a synthetic bioactive bone graft for cervical and lumbar spine fusion procedures. This product acts as a scaffold for bone growth, is reabsorbed and replaced by natural bone, and features an osteoconductive matrix made from carbonate apatite bone mineral, bioactive glass, and Type 1 collagen.

Xtant Medical’s Strategic Acquisition

• Acquisition Details: In August 2023, Xtant Medical acquired certain assets and liabilities of Surgalign Holdings Inc.’s biologics and spinal fixation products. This acquisition aims to expand Xtant Medical’s product portfolio and market presence in the orthopedic and spine surgery sectors.

Market Segmentation

• By Product: Bone Allografts, Bone Graft Substitutes, Platelet Rich Plasma, Bone Marrow Aspirate Therapy.
• By Surgery Type: Anterior Cervical Discectomy and Fusion (ACDF), Posterior Lumbar Interbody Fusion (PLIF), Transforaminal Lumbar Interbody Fusion (TLIF), Anterior Lumbar Interbody Fusion (ALIF), Lateral Lumbar Interbody Fusion (LLIF), Other Surgery Types.
• By Application: Spinal Fusion, Spinal Non-Union and Fracture Repair, Degenerative Disc Disease Treatment, Other Applications.
• By End User: Hospitals, Spinal Surgery Centers, Orthopedic Clinics, Other End Users.

Regional Insights

• Largest Region in 2023: North America was the largest region in the spine biologics market.
• Fastest-Growing Region: Asia-Pacific is expected to be the fastest-growing region in the forecast period, driven by advancements in healthcare infrastructure and increasing adoption of innovative medical technologies.

The spine biologics market is poised for steady growth, driven by technological advancements, increasing demand for minimally invasive procedures, and strategic industry movements. With ongoing innovations and expanding applications, this market promises significant improvements in spinal health and patient outcomes.

Request A Sample Of The Global Spine Biologics Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=15928&type=smp